We are thrilled to share our latest publication in the journal “ACS Medicinal Chemistry Letters” titled – A Shift in Thinking: Cellular Thermal Shift Assay-Enabled Drug Discovery.
In this study, we highlighted recently published applications of CETSA® and how the data generated can enable efficient decision-making and prioritization throughout the drug discovery and development value chain. Over the years, CETSA® method has guided numerous projects by providing insights about, for example, target engagement, lead generation, target identification, lead optimization, and preclinical profiling.
Follow this link to read the paper.